BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm)
1 clinical trials · Condition
◉ Watch BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm)
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN (NCT06690827) | Chongqing Precision Biotech Co., Ltd | 2024-11-13 |
Track BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm) automatically
Every clearance here is in the API, with alerts when new ones post.